|
ARID5B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.446000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.069430E-01 |
| Normal-vs-Stage2 |
9.991000E-01 |
| Normal-vs-Stage3 |
7.657800E-01 |
| Normal-vs-Stage4 |
7.983200E-01 |
| Stage1-vs-Stage2 |
2.905600E-01 |
| Stage1-vs-Stage3 |
1.818990E-01 |
| Stage1-vs-Stage4 |
3.779400E-01 |
| Stage2-vs-Stage3 |
8.433800E-01 |
| Stage2-vs-Stage4 |
8.492400E-01 |
| Stage3-vs-Stage4 |
9.881800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.476100E-02 |
| Normal-vs-AfricanAmerican |
2.987200E-01 |
| Normal-vs-Asian |
9.794000E-01 |
| Caucasian-vs-AfricanAmerican |
8.934000E-01 |
| Caucasian-vs-Asian |
1.458190E-01 |
| AfricanAmerican-vs-Asian |
3.083200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.348800E-01 |
| Normal-vs-Female |
3.198600E-01 |
| Male-vs-Female |
6.309000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.696400E-02 |
| Normal-vs-Age(41-60Yrs) |
8.389400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.500200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.607200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.065700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.155600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.731600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.803000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.897400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.858800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.245390E-01 |
| Classical-VS-Follicular |
7.48709999998098E-07 |
| Classical-VS-Other |
6.496200E-01 |
| Classical-VS-Normal |
2.228100E-02 |
| Tall-VS-Follicular |
8.325700E-02 |
| Tall-VS-Other |
8.731200E-01 |
| Tall-VS-Normal |
8.510000E-01 |
| Follicular-VS-Other |
2.572400E-01 |
| Follicular-VS-Normal |
5.711900E-02 |
| Other-VS-Normal |
7.658600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.399800E-01 |
| Normal-vs-N1 |
3.093000E-01 |
| N0-vs-N1 |
9.215800E-02 |
|
|
